| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
|
Table 2. The AF incidences between the four groups and the recovery in these groups after the treatment
Groups (n=40 in each group)
Treatment
No. of patients who developed AF
Spontaneous recovery
Medical recovery
Recovery after cardioversion
Discharged in AF
Heart rate
I
Atenolol (50 mg/day) and digoxin (0.25 mg/day)
2 (5%)
2
–
–
–
85±6
II
Digoxin (0.25 mg/day)
7 (17.9%)
2
4
1
–
114±15
III
Atenolol (50 mg/day)
6 (15.4%)
1
5
–
–
103±8
IV
Placebo
10 (25%)
2
6
1
1
126±15
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
